Literature DB >> 22053062

Emollients, education and quality of life: the RCPCH care pathway for children with eczema.

Helen Cox1, Kate Lloyd, Hywel Williams, Peter D Arkwright, Trevor Brown, Christine Clark, Margaret Campbell, Claudia Gore, Catherine Hardman, Andrew Langford, Sue Lewis-Jones, Sandra Lawton, Matthew Ridd, Lucia Russell, Dalbir Sohi, Rosemary Turnbull, Carina Venter, John O Warner.   

Abstract

OBJECTIVES: The Royal College of Paediatrics and Child Health (RCPCH) Science and Research Department was commissioned by the Department of Health to develop national care pathways for children with allergies. The eczema pathway focuses on defining the competences to improve the equity of care received by children with eczema.
METHOD: The eczema pathway was developed by a multidisciplinary working group and was based on a comprehensive review of evidence. The pathway was reviewed by a broad group of stakeholders including paediatricians, allergists, dermatologists, specialist nurses, dietician, patients' representatives and approved by the Allergy Care Pathways Project Board and the RCPCH Clinical Standards Committee. It was also reviewed by a wide range of stakeholders.
RESULTS: The results are presented in three sections: the evidence review, mapping and the core knowledge document. The various entry points to the ideal pathway of care are defined from self-care through to follow-up. There is considerable emphasis on good skin care and when allergy problems should be dealt with. The pathway algorithm and associated competences can be downloaded from http://www.rcpch.ac.uk/allergy/eczema.
CONCLUSIONS: Effective eczema management is holistic and encompasses an assessment of severity and impact on quality of life, treatment of the inflamed epidermal skin barrier, recognition and treatment of infection and assessment and management of environmental and allergy triggers. Patient and family education which seeks to maximise understanding and concordance with treatment is also important in all children with eczema.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22053062     DOI: 10.1136/archdischild-2011-300695

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

Review 1.  The role of antiseptic agents in atopic dermatitis.

Authors:  Melissa Lee; Hugo Van Bever
Journal:  Asia Pac Allergy       Date:  2014-10-29

2.  Developing a written action plan for children with eczema: a qualitative study.

Authors:  Kingsley Powell; Emma Le Roux; Jonathan P Banks; Matthew J Ridd
Journal:  Br J Gen Pract       Date:  2017-12-04       Impact factor: 5.386

3.  TEST (Trial of Eczema allergy Screening Tests): protocol for feasibility randomised controlled trial of allergy tests in children with eczema, including economic scoping and nested qualitative study.

Authors:  Matthew J Ridd; Louisa Edwards; Miriam Santer; Joanne R Chalmers; Lisa Waddell; Deborah Marriage; Ingrid Muller; Kirsty Roberts; Kirsty Garfield; Joanna Coast; Lucy Selman; Clare Clement; Alison R G Shaw; Elizabeth Angier; Peter S Blair; Nicholas L Turner; Jodi Taylor; Joe Kai; Robert J Boyle
Journal:  BMJ Open       Date:  2019-05-09       Impact factor: 2.692

Review 4.  Skin Barrier Function in Infants: Update and Outlook.

Authors:  Annisa Rahma; Majella E Lane
Journal:  Pharmaceutics       Date:  2022-02-17       Impact factor: 6.321

5.  The infant skin barrier: can we preserve, protect, and enhance the barrier?

Authors:  Lorena S Telofski; A Peter Morello; M Catherine Mack Correa; Georgios N Stamatas
Journal:  Dermatol Res Pract       Date:  2012-09-04

6.  GPs' experiences of diagnosing and managing childhood eczema: a qualitative study in primary care.

Authors:  Emma Le Roux; Kingsley Powell; Jonathan P Banks; Mathew J Ridd
Journal:  Br J Gen Pract       Date:  2018-01-15       Impact factor: 5.386

7.  The content and conduct of GP consultations for dermatology problems: a cross-sectional study.

Authors:  Emma Le Roux; Peter J Edwards; Emily Sanderson; Rebecca K Barnes; Matthew J Ridd
Journal:  Br J Gen Pract       Date:  2020-10-01       Impact factor: 5.386

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.